Instituto de Microbiologia Paulo de Goes, Univeridade Federal do Rio de Janeiro, Brazil; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Biomed Pharmacother. 2019 Jan;109:1547-1555. doi: 10.1016/j.biopha.2018.11.007. Epub 2018 Nov 14.
High-fat diet (HFD)-induced obesity is a worldwide health problem and can cause lipid accumulation in the liver. We evaluated the hepatoprotective effect of mate tea treatment in mice submitted to an HFD. C57BL/6 mice were fed an HFD for 13 weeks with and without mate tea. A separate group of mice was treated with fenofibrate as a positive control (a regular drug for lipid disorders). Histological analyses, glucose tolerance tests (GTT), and quantification of mediators related to lipid peroxidation, oxidative stress and blood biomarkers for lipid profile were performed. The weight of animals and major organs related to hepatic steatosis was determined, and proinflammatory cytokines and the participation of the Nrf2 pathway and adiponectin were evaluated. Mate tea prevented the accumulation of lipid droplets in hepatocytes as well as weight gain in animals submitted to the HFD. Mate tea treatment also prevented increases in the liver weight, heart weight and amount of visceral and subcutaneous white adipose tissue. Mate tea was able to prevent the deregulation of glucose uptake, as evaluated by GTT, and improved the indicators of oxidative stress, such as nitrite levels, catalase activity, and oxidative damage, as evaluated by protein carbonylation and the MDA levels. Mate tea had an anti-inflammatory effect, preventing the increase of IL-1β and KC and upregulating the expression of Nrf2. Mate tea prevented insulin increase and HDL cholesterol decrease but did not affect total cholesterol or triglycerides levels. Treatment also prevented adiponectin increase. Mate tea may be a good resource to reduce hepatic steatosis in the future since it has anti-diabetic, anti-inflammatory and antioxidant effects, which prevent the accumulation of fat in the liver.
高脂饮食(HFD)诱导的肥胖是一个全球性的健康问题,可导致肝脏脂质积累。我们评估了马黛茶处理对 HFD 诱导肥胖小鼠的保肝作用。C57BL/6 小鼠接受 HFD 喂养 13 周,同时给予或不给予马黛茶。另一组小鼠用非诺贝特作为阳性对照(一种用于治疗脂质紊乱的常规药物)进行治疗。进行组织学分析、葡萄糖耐量试验(GTT)以及与脂质过氧化、氧化应激和血脂生物标志物相关的介质的定量分析。测定动物体重和与肝脂肪变性相关的主要器官的重量,并评估促炎细胞因子以及 Nrf2 通路和脂联素的参与情况。马黛茶可防止 HFD 诱导的肝细胞内脂质滴的积累以及动物体重增加。马黛茶处理还可防止肝重、心脏重以及内脏和皮下白色脂肪组织量的增加。马黛茶可防止 GTT 评估的葡萄糖摄取失调,并改善氧化应激指标,如亚硝酸盐水平、过氧化氢酶活性以及通过蛋白质羰基化和 MDA 水平评估的氧化损伤。马黛茶具有抗炎作用,可防止 IL-1β 和 KC 的增加,并上调 Nrf2 的表达。马黛茶可防止胰岛素增加和 HDL 胆固醇降低,但不影响总胆固醇或甘油三酯水平。治疗还可防止脂联素增加。马黛茶可能是未来减少肝脂肪变性的良好资源,因为它具有抗糖尿病、抗炎和抗氧化作用,可防止脂肪在肝脏中积累。